RedLens vs Prisma AIRS
Prisma AIRS is the biggest, best-funded platform in this market. RedLens is the vertical tool built around regulated-sector evidence.
Prisma AIRS pairs a red-teaming agent with model scanning and runtime security across the Palo Alto stack. RedLens is narrower, built around compliance evidence and published pricing. We make RedLens, so weigh this accordingly; every Prisma AIRS claim is sourced and dated.
Prisma AIRS facts checked 18 October 2026What each one is
Prisma AIRS
Palo Alto Networks' AI security platform, built partly on the acquired Protect AI technology. Its Dynamic Red Teaming Agent and attack library test LLMs, LLM applications and agent behaviour, including whether an agent executes a task it was not designed to do or produces off-brand output; a January 2026 update added an AI risk summary and brand-reputation risk detection. It reaches internal models without opening inbound ports, with connectors for Microsoft Copilot Studio, n8n and Gemini Agent Studio, and pairs red teaming with model and supply-chain scanning and AI runtime security across the Palo Alto stack. Pricing is quote-based and not public.
RedLens
A younger, vertical platform: real adversarial attacks across 6 categories and 22 methodologies, with a compliance evidence package on every finding. Focus is regulated sectors: citation-level HIPAA and FBI CJIS mapping with evidence grading, a healthcare-restricted curated-only methodology, and synthetic PHI and CJI sandboxes so no real data enters a test. Publishes four tiers with a free hosted tier. Early-stage and pre-revenue, with fewer deployments and a shorter track record than Prisma AIRS.
Side by side
The RedLens column is highlighted. This scores depth and fit, not an overall winner.
| Capability | RedLens | Prisma AIRS |
|---|---|---|
| Automated adversarial attacks | 6 categories, 22 methodologies | Dynamic Red Teaming Agent + attack library |
| Agent behaviour testing | IPI, TCH, AAA, MMP, MCD, MTP | agent misuse; Copilot/n8n/Gemini connectors |
| Citation-level HIPAA / CJIS mapping | per finding, evidence-graded | aligned to frameworks, not per-control HIPAA/CJIS |
| Model-file / supply-chain scanning | not offered | Protect AI lineage |
| Inline / runtime security | Runtime Guard finds and flags | AI runtime security |
| Ecosystem / scale | early-stage | Palo Alto stack; biggest, best-funded |
| Published pricing | Free $0 to Enterprise $150k/yr+ | quote-based / not public |
| Free / self-serve start | 25 scans/mo | demo / sales |
| Deployment | SaaS; on-premise on Enterprise | SaaS; private endpoint reach, no inbound ports |
Where Prisma AIRS is the stronger choice
Several places. Prisma AIRS is the biggest and best-funded option in this market, and its breadth is real: a red-teaming agent, model and supply-chain scanning and AI runtime security in one platform across the Palo Alto stack. It reaches internal models without opening inbound ports, carries connectors for Microsoft Copilot Studio, n8n and Gemini Agent Studio, and added brand-reputation risk detection in January 2026. If you are a Palo Alto shop wanting one vendor across network, cloud and AI, Prisma AIRS wins on breadth and scale and RedLens covers only part of that surface.
Where RedLens is the stronger choice
RedLens wins on a narrow axis: regulated-sector evidence and accessibility. If you need findings a privacy officer or a CJIS Systems Officer will accept, the citation-level HIPAA and CJIS mapping with evidence grading is the thing to test for; Prisma AIRS aligns findings to frameworks but not to those control sets per finding. The healthcare-restricted methodology and synthetic PHI and CJI sandboxes matter when you cannot put real data into a test, and published pricing from $0 means a lean team can start without a sales cycle.
On pricing and procurement
The pricing models differ. Prisma AIRS is quote-based through Palo Alto sales, which fits an enterprise already buying across the Palo Alto stack. RedLens publishes four tiers: Free at $0 with 25 hosted scans a month, Team at $199/mo, Professional at $8,000/mo, and Enterprise from $150k/yr. For a community hospital, a small agency, or a team that wants to try before it talks to sales, a published entry tier removes the first barrier. Neither model is better; they suit different buyers.
No model-file scanning, no inline runtime guard, no DLP breadth, no org-wide shadow-AI governance beyond discovery, and no FedRAMP or CJIS authorization. RedLens is not an all-in-one AI security suite, and it is newer and less proven than Prisma AIRS.
Comparison pages written by a vendor are worth reading skeptically. Our discipline: every Prisma AIRS capability here is drawn from Prisma AIRS's own materials or dated third-party coverage, the table marks vendor-stated claims as such, and the “where Prisma AIRS is stronger” section is not a throwaway. If Prisma AIRS finds a line that is wrong or out of date, the correction address is below and we will fix it within a week.
Who should pick which
- Pick Prisma AIRS if you want breadth, red teaming plus model and supply-chain scanning and AI runtime security in one platform, you are standardised on Palo Alto, and you are comfortable with quote-based enterprise pricing.
- Pick RedLens if you are a lean healthcare or law-enforcement team, need HIPAA or CJIS evidence per finding, want to test with synthetic regulated data, and want to start on a published, self-serve tier.
The cheapest way to decide is to run both against your own system.
Frequently asked
Is RedLens or Prisma AIRS better?
Neither is better in the abstract. Prisma AIRS is the broader, better-funded platform and the safer pick for an organisation standardised on Palo Alto that wants breadth across red teaming, scanning and runtime security. RedLens is the vertical, regulated-sector tool with citation-level HIPAA and CJIS evidence and published pricing from $0, best for a lean healthcare or law-enforcement team.
Does Prisma AIRS publish pricing?
No. As of October 2026 Palo Alto Networks does not publish list pricing for Prisma AIRS; it is quote-based through Palo Alto sales. RedLens publishes four tiers: Free $0, Team $199/mo, Professional $8,000/mo, and Enterprise from $150k/yr.
What does Prisma AIRS do that RedLens does not?
Model-file and supply-chain scanning, AI runtime security, brand-reputation risk detection, and breadth across the Palo Alto stack, at a scale RedLens does not match. RedLens does not do model-file scanning and is earlier-stage.
See the evidence format in minutes
The RedLens free attack test shows the finding and evidence format against a target, no card required.
Prisma AIRS, if we have described anything inaccurately, email sales@redlens.ai and we will correct it within a week.